Search

Your search keyword '"Tam, Amy"' showing total 179 results

Search Constraints

Start Over You searched for: Author "Tam, Amy" Remove constraint Author: "Tam, Amy"
179 results on '"Tam, Amy"'

Search Results

1. Biallelic variants in RINT1 present as early-onset pure hereditary spastic paraplegia

3. Dissecting the Regulatory Strategies of NF-κB RelA Target Genes in the Inflammatory Response Reveals Differential Transactivation Logics

4. Impacts of fast production of afucosylated antibodies and Fc mutants in ExpiCHO-S™ for enhancing FcγRIIIa binding and NK cell activation

5. Juvenile‐onset Huntington's disease – Spectrum and evolution of presenting movement disorders.

6. Recommendations for the Management of Initial and Refractory Pediatric Status Dystonicus.

7. The spectrum of movement disorders in young children with ARX‐related epilepsy‐dyskinesia syndrome

12. The Association of Patients’ Oral Health Literacy and Dental School Communication Tools: A Pilot Study

13. Exploring Parametric and Mechanistic Differences between Expi293FTM and ExpiCHO-STM Cells for Transient Antibody Production Optimization

14. Plasma Neurofilament Light Chain Is Elevated in Adaptor Protein Complex 4‐Related Hereditary Spastic Paraplegia

19. Exploring Parametric and Mechanistic Differences between Expi293F TM and ExpiCHO-S TM Cells for Transient Antibody Production Optimization.

20. Site Selection: a Case Study in the Identification of Optimal Cysteine Engineered Antibody Drug Conjugates

21. Discovery and multi-parametric optimization of a high-affinity antibody against interleukin-25 with neutralizing activity in a mouse model of skin inflammation

24. MaveDB v2: a curated community database with over three million variant effects from multiplexed functional assays

26. A search for protein biomarkers links olfactory signal transduction to social immunity

28. Genetic rearrangement during site specific integration event facilitates cell line development of a bispecific molecule

29. Discovery and optimization of a novel anti-GUCY2c x CD3 bispecific antibody for the treatment of solid tumors

30. CDR-restricted engineering of native human scFvs creates highly stable and soluble bifunctional antibodies for subcutaneous delivery

31. Modeling and mitigation of high-concentration antibody viscosity through structure-based computer-aided protein design

33. A novel approach to identifying β-secretase inhibitors: Bis-statine peptide mimetics discovered using structure and spot synthesis

34. Biallelic Variants in COQ4 Cause Childhood‐Onset Pure Hereditary Spastic Paraplegia.

35. Prevalence of Cariogenic Microbial Flora among Scardovia wiggsiae-Positive and Negative Patients

37. Transient CHO expression platform for robust antibody production and its enhanced N‐glycan sialylation on therapeutic glycoproteins

38. Buried Versus Exposed Kirschner Wires Following Fixation of Hand Fractures

39. Glyco-engineered Long Acting FGF21 Variant with Optimal Pharmaceutical and Pharmacokinetic Properties to Enable Weekly to Twice Monthly Subcutaneous Dosing

40. Establishing in vitro in vivo correlations to screen monoclonal antibodies for physicochemical properties related to favorable human pharmacokinetics

48. A Combination of Structural and Empirical Analyses Delineates the Key Contacts Mediating Stability and Affinity Increases in an Optimized Biotherapeutic Single-chain Fv (scFv)

49. A search for protein biomarkers links olfactory signal transduction to social immunity

50. Establishing in vitro in vivocorrelations to screen monoclonal antibodies for physicochemical properties related to favorable human pharmacokinetics

Catalog

Books, media, physical & digital resources